Edwards Lifesciences Duraflo coated Femoral Cannula. Product Usage: The cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin-coated blood path is desired. The femoral arterial cannulae are wire-reinforced, thin-wall cannulae.
Publicado el 24 de abril de 2013 · Inicio del retiro: 14 de marzo de 2013
Resumen
FDA registra el retiro Z-1111-2013 de dispositivos médicos de Clase II, publicado el 24 de abril de 2013 e iniciado el 14 de marzo de 2013. Empresa responsable: Edwards Lifesciences, LLC; Estado: Finalizado; Cantidad reportada: 379 units; Lote: Model DIIFEMII018A, Lot 59337174. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Two unsealed pouches were found at an Edwards' distribution location in Japan. Incorrectly sealed pouches may result in a sterility barrier breach.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Edwards Lifesciences, LLC
- Distribuidor
- USA Nationwide Distribution including the states of: FL, MA, MI, NY, PA, TX.
- Lote
- Model DIIFEMII018A, Lot 59337174
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAGeneric Name: Edwards Commander M Delivery System Generic Name: Edwards Commander M Delivery System11 de noviembre de 2026
- FDAEdwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO20 de mayo de 2026
- FDABrand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016AS Software16 de julio de 2025
- FDABrand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI1616 de julio de 2025
- FDAIS3000 USER MANUAL for Intuitive Surgical da Vinci Si Surgical System and da Vinci Si-e Surgical System, Model24 de abril de 2013
- FDAAlaris PC unit model 8015 with software version 9.12 Product Usage: The Alaris PC unit is the central24 de abril de 2013
Preguntas sobre este retiro
¿Edwards Lifesciences Duraflo coated Femoral Cannula. Product Usage: The cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin-coated blood path is desired. The femoral arterial cannulae are wire-reinforced, thin-wall cannulae. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1111-2013 el 24 de abril de 2013. Peligro reportado: Two unsealed pouches were found at an Edwards' distribution location in Japan. Incorrectly sealed pouches may result in a sterility barrier breach.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter